Welcome to LookChem.com Sign In|Join Free
  • or
3-(3-pyridyl)-5-(2-chlorophenyl)-1,2,4-oxadiazole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

27199-48-0

Post Buying Request

27199-48-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27199-48-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 27199-48-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,1,9 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 27199-48:
(7*2)+(6*7)+(5*1)+(4*9)+(3*9)+(2*4)+(1*8)=140
140 % 10 = 0
So 27199-48-0 is a valid CAS Registry Number.

27199-48-0Downstream Products

27199-48-0Relevant academic research and scientific papers

Synthesis and antibacterial evaluation of 3,5-Diaryl-1,2,4-oxadiazole derivatives

Cunha, Felipe S.,Nogueira, Joseli M. R.,De Aguiar, Alcino P.

, p. 2405 - 2416 (2018/10/20)

This manuscript reports the synthesis of twenty 3,5-diaryl-1,2,4-oxadiazole derivatives, nine of which are novel compounds. The amidoxime reaction with acyl chlorides obtained from substituted benzoic acids was used. All compounds were tested against five standard (American Type Culture Collection (ATCC)) bacteria: Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecalis, Proteus mirabilis and Staphylococcus aureus. Screening assays were carried out using agar-diffusion technique, in which 100 μM heterocyclic compounds solutions (20percent dimethylsulfoxide/water) were employed. The minimum inhibitory concentrations (MIC) of the active compounds were determined by serial dilutions at decreasing concentrations in microtiter plates. The nitrated derivatives gave the best test results, where MIC = 60 μM (E. coli) was the lowest value found for an ortho-nitrated derivative. The activity of these compounds possibly involves a mechanism via free radicals. S. aureus and P. aeruginosa were resistant to all compounds.

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

-

, (2008/06/13)

The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 27199-48-0